Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

July 2, 2021

Study Completion Date

May 15, 2022

Conditions
Esophageal DilationRefractory Benign Esophageal Stricture
Interventions
DEVICE

Esophageal self-dilation therapy

Patient learns to pass a polyvinyl dilator orally on a routine basis. Teaching will take over 1-3 training sessions by one of two esophageal physicians and a nurse. Patients will be instructed to start Esophageal self dilation therapy twice a day for at least one week.

PROCEDURE

Endoscopic therapy with esophageal dilation

A long, flexible tube is inserted down the throat into the esophagus and the narrow area of the esophagus is dilated, or stretched.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03738566 - Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management | Biotech Hunter | Biotech Hunter